Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CIN

Purpose Among the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the commonest offered in the UK, whereas thermal ablation (TA) has not been common in several decades, despite several notable advantages. TA and...

Full description

Saved in:
Bibliographic Details
Published inArchives of gynecology and obstetrics Vol. 306; no. 5; pp. 1815 - 1820
Main Authors Armstrong, G. M., Ragupathy, K.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.11.2022
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose Among the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the commonest offered in the UK, whereas thermal ablation (TA) has not been common in several decades, despite several notable advantages. TA and LLETZ are both routinely undertaken in our colposcopy unit, and extensive follow-up data have been used to interrogate outcomes between the two modalities and determine whether one modality may be preferred over the other. Methods Up to 8 years of follow-up data (cytology and histology) were collected for patients who have undergone LLETZ or TA and failed post-treatment test of cure (ToC). These data were analysed and used to plot Kaplan–Meier survival curves, in order to compare outcomes: negative cytology, dyskaryosis, low- and high-grade CIN and invasive squamous cell carcinoma. Results i) Very few women treated with TA developed recurrent high-grade CIN in the follow-up period; (ii) LLETZ-treated women had a significantly higher rate of recurrence than those treated by TA; (iii) women who failed both virology and cytology components of post-treatment ToC had higher recurrence than those who failed only one, and the rate of recurrence was highest in those treated by LLETZ (> 65%). Conclusion TA is an effective treatment of high-grade CIN, with a high chance of achieving double-negative ToC and low recurrence relative to LLETZ. We recommend the wider adoption of TA, so that young women of reproductive age have a choice of treatment with no reported adverse effects on pregnancy outcomes.
AbstractList Purpose Among the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the commonest offered in the UK, whereas thermal ablation (TA) has not been common in several decades, despite several notable advantages. TA and LLETZ are both routinely undertaken in our colposcopy unit, and extensive follow-up data have been used to interrogate outcomes between the two modalities and determine whether one modality may be preferred over the other. Methods Up to 8 years of follow-up data (cytology and histology) were collected for patients who have undergone LLETZ or TA and failed post-treatment test of cure (ToC). These data were analysed and used to plot Kaplan–Meier survival curves, in order to compare outcomes: negative cytology, dyskaryosis, low- and high-grade CIN and invasive squamous cell carcinoma. Results i) Very few women treated with TA developed recurrent high-grade CIN in the follow-up period; (ii) LLETZ-treated women had a significantly higher rate of recurrence than those treated by TA; (iii) women who failed both virology and cytology components of post-treatment ToC had higher recurrence than those who failed only one, and the rate of recurrence was highest in those treated by LLETZ (> 65%). Conclusion TA is an effective treatment of high-grade CIN, with a high chance of achieving double-negative ToC and low recurrence relative to LLETZ. We recommend the wider adoption of TA, so that young women of reproductive age have a choice of treatment with no reported adverse effects on pregnancy outcomes.
PURPOSEAmong the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the commonest offered in the UK, whereas thermal ablation (TA) has not been common in several decades, despite several notable advantages. TA and LLETZ are both routinely undertaken in our colposcopy unit, and extensive follow-up data have been used to interrogate outcomes between the two modalities and determine whether one modality may be preferred over the other. METHODSUp to 8 years of follow-up data (cytology and histology) were collected for patients who have undergone LLETZ or TA and failed post-treatment test of cure (ToC). These data were analysed and used to plot Kaplan-Meier survival curves, in order to compare outcomes: negative cytology, dyskaryosis, low- and high-grade CIN and invasive squamous cell carcinoma. RESULTSi) Very few women treated with TA developed recurrent high-grade CIN in the follow-up period; (ii) LLETZ-treated women had a significantly higher rate of recurrence than those treated by TA; (iii) women who failed both virology and cytology components of post-treatment ToC had higher recurrence than those who failed only one, and the rate of recurrence was highest in those treated by LLETZ (> 65%). CONCLUSIONTA is an effective treatment of high-grade CIN, with a high chance of achieving double-negative ToC and low recurrence relative to LLETZ. We recommend the wider adoption of TA, so that young women of reproductive age have a choice of treatment with no reported adverse effects on pregnancy outcomes.
Among the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the commonest offered in the UK, whereas thermal ablation (TA) has not been common in several decades, despite several notable advantages. TA and LLETZ are both routinely undertaken in our colposcopy unit, and extensive follow-up data have been used to interrogate outcomes between the two modalities and determine whether one modality may be preferred over the other. Up to 8 years of follow-up data (cytology and histology) were collected for patients who have undergone LLETZ or TA and failed post-treatment test of cure (ToC). These data were analysed and used to plot Kaplan-Meier survival curves, in order to compare outcomes: negative cytology, dyskaryosis, low- and high-grade CIN and invasive squamous cell carcinoma. i) Very few women treated with TA developed recurrent high-grade CIN in the follow-up period; (ii) LLETZ-treated women had a significantly higher rate of recurrence than those treated by TA; (iii) women who failed both virology and cytology components of post-treatment ToC had higher recurrence than those who failed only one, and the rate of recurrence was highest in those treated by LLETZ (> 65%). TA is an effective treatment of high-grade CIN, with a high chance of achieving double-negative ToC and low recurrence relative to LLETZ. We recommend the wider adoption of TA, so that young women of reproductive age have a choice of treatment with no reported adverse effects on pregnancy outcomes.
Author Armstrong, G. M.
Ragupathy, K.
Author_xml – sequence: 1
  givenname: G. M.
  orcidid: 0000-0003-3052-6292
  surname: Armstrong
  fullname: Armstrong, G. M.
  email: gregory.armstrong@ggc.scot.nhs.uk
  organization: University of Dundee
– sequence: 2
  givenname: K.
  surname: Ragupathy
  fullname: Ragupathy, K.
  organization: Obstetrics and Gynaecology Department, NHS Tayside, Ninewells Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35107616$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi3Uin7AH-CALHHhkuJvJxyQqlWhlVbtZU9crEky2U2V2IudVNp_j7fblsKBk229z7wz4_eMHPngkZAPnF1wxuyXxJhiqmBCFMwoVhXyDTnlSuan5fzo1f2EnKV0zxgXZWnekhOpObOGm1PSrTBNNHS0mSNS8C2tcRd8-5WmeYuxD7Gfdnt92mAcYaBQDzD1wdPwgJEul1ern7T3e5lOEWEa0T_6bfr1plhHaJEubm7fkeMOhoTvn85zsvp-tVpcF8u7HzeLy2XRKKGnQikJ0MhKdCBNjVq3ttMaSqFF3bSmLk2ly1aUTFihLHLktax0DcZAyRjIc_LtYLud6xHbJs8SYXDb2I8Qdy5A7_5WfL9x6_DgKs0rY3U2-PxkEMOvOX-NG_vU4DCAxzAnJ4xQlRZS24x--ge9D3P0eTsnLC-t4hXbU-JANTGkFLF7GYYzt0_RHVJ0OUX3mKKTuejj6zVeSp5jy4A8AClLfo3xT-__2P4GLcipLA
Cites_doi 10.1111/1471-0528.2012.03505.x
10.1136/jcp.47.9.799
10.1002/cncr.30588
10.1097/LGT.0000000000000031
10.1111/j.1471-0528.1993.tb15273.x
10.1111/1471-0528.12655
10.1016/j.vaccine.2012.06.095
10.1016/j.semcancer.2013.11.002
10.1136/bmj.i3633
10.1097/00003081-198312000-00022
10.1007/s00404-017-4306-z
10.1111/j.1471-0528.2011.02944.x
10.1016/0002-9378(66)90546-1
10.1002/14651858.CD001318.pub2
10.1002/ijc.33290
10.1016/S0950-3552(05)80363-3
10.1111/j.1471-0528.1991.tb10304.x
10.1002/ijc.29210
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1007/s00404-022-06409-3
DatabaseName SpringerOpen
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest One Academic Eastern Edition
PubMed
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: ProQuest_Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-0711
EndPage 1820
ExternalDocumentID 10_1007_s00404_022_06409_3
35107616
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
2.D
203
23N
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
7X7
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PT4
PT5
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z7X
Z81
Z82
Z83
Z87
Z8O
Z8Q
Z8U
Z8V
Z8W
Z91
ZMTXR
ZOVNA
ZXP
~EX
AACDK
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
NPM
AAYXX
CITATION
3V.
7XB
8FK
K9.
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c425t-443aac392fa36be55d7f55a8252bcd6b86958d28027247e1e1b395ba66a800a3
IEDL.DBID 7X7
ISSN 1432-0711
0932-0067
IngestDate Tue Sep 17 21:30:40 EDT 2024
Wed Dec 04 04:37:49 EST 2024
Tue Oct 22 17:27:55 EDT 2024
Fri Dec 06 05:59:41 EST 2024
Wed Oct 16 00:42:17 EDT 2024
Sat Dec 16 12:07:10 EST 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Thermal ablation
LLETZ
CIN
Colposcopy
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c425t-443aac392fa36be55d7f55a8252bcd6b86958d28027247e1e1b395ba66a800a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3052-6292
OpenAccessLink https://proxy.k.utb.cz/login?url=http://link.springer.com/10.1007/s00404-022-06409-3
PMID 35107616
PQID 2718741907
PQPubID 4408561
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9519675
proquest_miscellaneous_2624952357
proquest_journals_2718741907
crossref_primary_10_1007_s00404_022_06409_3
pubmed_primary_35107616
springer_journals_10_1007_s00404_022_06409_3
PublicationCentury 2000
PublicationDate 2022-11-01
PublicationDateYYYYMMDD 2022-11-01
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Archives of gynecology and obstetrics
PublicationTitleAbbrev Arch Gynecol Obstet
PublicationTitleAlternate Arch Gynecol Obstet
PublicationYear 2022
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References KyrgiouMAthanasiouAParaskevaidiMMitraAKallialaIMartin-HischPAdverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: a systematic review and meta-analysisBMJ201635410.1136/bmj.i3633
SemmKNew apparatus for the ‘cold-coagulation’ of benign cervical lesionsAm J Obstet Gynecol19669579639661:STN:280:DyaF2s%2Fgs1yisA%3D%3D10.1016/0002-9378(66)90546-1
WilliamsOEBodhaMAlawattegamaABOutcome of cold coagulation for the treatment of cervical intraepithelial neoplasia in a department of genitourinary medicineGenitourin Med199369163651:STN:280:DyaK3s7os1WmtQ%3D%3D84444851195014
FerlayJSoerjomataramIDikshitREserSMathersCRebeloMCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E3593861:CAS:528:DC%2BC2cXitVyktbzI10.1002/ijc.29210
Cancer Research UK, https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer. Accessed Jun 2021.
BruinismaFQuinnMThe risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysisBJOG201111891031104110.1111/j.1471-0528.2011.02944.x
Parry-SmithWUnderwoodMDe Bellis-AyresSBangsLRedmanCWPanikkarJSuccess rate of cold coagulation for the treatment of cervical intraepithelial neoplasia: a retrospective analysis of a series of casesJ Low Genit Tract Dis2015191172110.1097/LGT.0000000000000031
PapoutsisDUnderwoodMParry-SmithWPanikkarComparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort studyArch Gynecol Obstet2017295497998610.1007/s00404-017-4306-z
DuncanIDThe Semm cold coagulator in the management of cervical intraepithelial neoplasiaClin Obstet Gynecol198326499610061:STN:280:DyaL2c7gslejsA%3D%3D10.1097/00003081-198312000-00022
GordonHKDuncanIDEffective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100 degrees C using the Semm cold coagulator: 14 years experienceBr J Obstet Gynaecol199198114201:STN:280:DyaK3M7ltF2ltg%3D%3D10.1111/j.1471-0528.1991.tb10304.x
LoobuyckHADuncanIDDestruction of CIN 1 and 2 with the Semm cold coagulator: 13 years’ experience with a see-and-treat policyBr J Obstet Gynaecol199310054654681:STN:280:DyaK3s3pvVOhsQ%3D%3D10.1111/j.1471-0528.1993.tb15273.x
ArbynMRoncoGAnttilaAMeijerCJLMPoljakMOgilvieGEvidence regarding human papillomavirus testing in secondary prevention of cervical cancerVaccine201230Suppl 5F889910.1016/j.vaccine.2012.06.095
O’DwyerVMaddenMHickeyKCold coagulation to treat cervical intraepithelial neoplasiaBJOG Int J Obstet Gynaecol2013120451051010.1111/1471-0528.2012.03505.x
DolmanLSauvagetCMuwongeRSankaranarayananRMeta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic reviewBJOG201412189299421:STN:280:DC%2BC2crgvFajuw%3D%3D10.1111/1471-0528.12655
ZhaoX-LLiuZ-HZhaoSHuS-YMuwongeRDuanX-ZDuL-JSuC-FXiangX-EZhangXPanQ-JQiaoY-LSankaranarayananRZhaoF-HBasuPEfficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in ChinaInt J Cancer20211486141914271:CAS:528:DC%2BB3cXhvVWlsrjE10.1002/ijc.33290
DuncanIDCold coagulationBaillieres Clin Obstet Gynaecol1995911451551:STN:280:DyaK2MzisVWhsA%3D%3D10.1016/S0950-3552(05)80363-3
BermanTASchillerJTHuman papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseasesCancer2017123122219222910.1002/cncr.30588
TommasinoMThe human papillomavirus family and its role in carcinogenesisSemin Cancer Biol20142613211:CAS:528:DC%2BC2cXlvVKn10.1016/j.semcancer.2013.11.002
Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL (2010) Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev (6):CD001318.
Al-NafussiAIHughesDEHistological features of CIN3 and their value in predicting invasive microinvasive squamous carcinomaJ Clin Path19944797998041:STN:280:DyaK2M%2FltFKlsw%3D%3D10.1136/jcp.47.9.799
ID Duncan (6409_CR6) 1983; 26
AI Al-Nafussi (6409_CR14) 1994; 47
D Papoutsis (6409_CR17) 2017; 295
TA Berman (6409_CR4) 2017; 123
M Arbyn (6409_CR5) 2012; 30
X-L Zhao (6409_CR18) 2021; 148
ID Duncan (6409_CR7) 1995; 9
W Parry-Smith (6409_CR15) 2015; 19
J Ferlay (6409_CR2) 2015; 136
M Tommasino (6409_CR3) 2014; 26
6409_CR1
V O’Dwyer (6409_CR13) 2013; 120
K Semm (6409_CR11) 1966; 95
OE Williams (6409_CR10) 1993; 69
F Bruinisma (6409_CR19) 2011; 118
HA Loobuyck (6409_CR9) 1993; 100
HK Gordon (6409_CR8) 1991; 98
M Kyrgiou (6409_CR20) 2016; 354
6409_CR12
L Dolman (6409_CR16) 2014; 121
References_xml – volume: 120
  start-page: 510
  issue: 4
  year: 2013
  ident: 6409_CR13
  publication-title: BJOG Int J Obstet Gynaecol
  doi: 10.1111/1471-0528.2012.03505.x
  contributor:
    fullname: V O’Dwyer
– volume: 47
  start-page: 799
  issue: 9
  year: 1994
  ident: 6409_CR14
  publication-title: J Clin Path
  doi: 10.1136/jcp.47.9.799
  contributor:
    fullname: AI Al-Nafussi
– volume: 123
  start-page: 2219
  issue: 12
  year: 2017
  ident: 6409_CR4
  publication-title: Cancer
  doi: 10.1002/cncr.30588
  contributor:
    fullname: TA Berman
– volume: 19
  start-page: 17
  issue: 1
  year: 2015
  ident: 6409_CR15
  publication-title: J Low Genit Tract Dis
  doi: 10.1097/LGT.0000000000000031
  contributor:
    fullname: W Parry-Smith
– volume: 100
  start-page: 465
  issue: 5
  year: 1993
  ident: 6409_CR9
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.1993.tb15273.x
  contributor:
    fullname: HA Loobuyck
– volume: 121
  start-page: 929
  issue: 8
  year: 2014
  ident: 6409_CR16
  publication-title: BJOG
  doi: 10.1111/1471-0528.12655
  contributor:
    fullname: L Dolman
– ident: 6409_CR1
– volume: 30
  start-page: F88
  issue: Suppl 5
  year: 2012
  ident: 6409_CR5
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.06.095
  contributor:
    fullname: M Arbyn
– volume: 26
  start-page: 13
  year: 2014
  ident: 6409_CR3
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2013.11.002
  contributor:
    fullname: M Tommasino
– volume: 354
  year: 2016
  ident: 6409_CR20
  publication-title: BMJ
  doi: 10.1136/bmj.i3633
  contributor:
    fullname: M Kyrgiou
– volume: 26
  start-page: 996
  issue: 4
  year: 1983
  ident: 6409_CR6
  publication-title: Clin Obstet Gynecol
  doi: 10.1097/00003081-198312000-00022
  contributor:
    fullname: ID Duncan
– volume: 295
  start-page: 979
  issue: 4
  year: 2017
  ident: 6409_CR17
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-017-4306-z
  contributor:
    fullname: D Papoutsis
– volume: 69
  start-page: 63
  issue: 1
  year: 1993
  ident: 6409_CR10
  publication-title: Genitourin Med
  contributor:
    fullname: OE Williams
– volume: 118
  start-page: 1031
  issue: 9
  year: 2011
  ident: 6409_CR19
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2011.02944.x
  contributor:
    fullname: F Bruinisma
– volume: 95
  start-page: 963
  issue: 7
  year: 1966
  ident: 6409_CR11
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/0002-9378(66)90546-1
  contributor:
    fullname: K Semm
– ident: 6409_CR12
  doi: 10.1002/14651858.CD001318.pub2
– volume: 148
  start-page: 1419
  issue: 6
  year: 2021
  ident: 6409_CR18
  publication-title: Int J Cancer
  doi: 10.1002/ijc.33290
  contributor:
    fullname: X-L Zhao
– volume: 9
  start-page: 145
  issue: 1
  year: 1995
  ident: 6409_CR7
  publication-title: Baillieres Clin Obstet Gynaecol
  doi: 10.1016/S0950-3552(05)80363-3
  contributor:
    fullname: ID Duncan
– volume: 98
  start-page: 14
  issue: 1
  year: 1991
  ident: 6409_CR8
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.1991.tb10304.x
  contributor:
    fullname: HK Gordon
– volume: 136
  start-page: E359
  issue: 5
  year: 2015
  ident: 6409_CR2
  publication-title: Int J Cancer
  doi: 10.1002/ijc.29210
  contributor:
    fullname: J Ferlay
SSID ssj0012886
Score 2.3612158
Snippet Purpose Among the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the...
Among the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the commonest...
PurposeAmong the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the...
PURPOSEAmong the treatment modalities for high-grade cervical intraepithelial neoplasia (CIN), large-loop excision of the transformation zone (LLETZ) is the...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1815
SubjectTerms Ablation
Cellular biology
Cervical cancer
DNA methylation
Endocrinology
Gynecology
Histology
Human Genetics
Human papillomavirus
Medical screening
Medicine
Medicine & Public Health
Mortality
Obstetrics
Obstetrics/Perinatology/Midwifery
Original
Original Article
Patients
Software
Virology
Womens health
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BKyEupTwb2iIjcQNXxIntmFtVbSnQ9hSkwiWyHbtUiCzabi78embyqpalhyrHmSS2Z8b-rHkBvPFZtO69qbksYuA5AgRuhQ1cmgwfLUQfm3N2rk6-5p8v5MVNHncX7D56JLuNesp1I3XLOQWfk_PJ8Ow-bOLZQ9a4efjx25fZ5DwQRaGG_Jj_v7l6Bq0By_X4yH-cpN3Zc_wIyjGDpw85-XnQLt2B_7Ne0PEu09qGrQGLssNeeR7DvdA8gQdng7f9KcQSx8vmkfl2EZhtaua6fJcP7LqlAslzanxHdAKRv_BL1vWRdYziQtnp6az8zq4aIrMpoJ34qUYyv1zYOrCjT-fPoDyelUcnfOjLwD1a-JLneWatR2AVbaZckLLWUUqLd03hfK1coYwsalHgjVfkOqQhdZmRziplEZ7a7DlsNPMm7ACLXqbWyOhrI_OY4oZnjdfaI4pSCDRlAm9HQVW_--ob1VRnuVu5Cleu6lauyhLYG2VZDZZ4XQlNXQcR9ugEXk9ktCFyjNgmzFvkUdSBmwr_JPCiF_30uww3La1SlYBeUYqJgepzr1Kaqx9dnW4ErwbvYwm8G0V_M6zbZ_Hybuy78FCQ9nTpkXuwsVy0YR9x0tK9GuziL16_CR8
  priority: 102
  providerName: Springer Nature
Title Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CIN
URI https://link.springer.com/article/10.1007/s00404-022-06409-3
https://www.ncbi.nlm.nih.gov/pubmed/35107616
https://www.proquest.com/docview/2718741907
https://search.proquest.com/docview/2624952357
https://pubmed.ncbi.nlm.nih.gov/PMC9519675
Volume 306
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLdgkxAviO8VxhQk3iCCpk1y4QUdpxsDthNCN-ngpUrSBPZAO-7j_8dOe52OCVSplZoobezE-Tl2bIAXvojWvTE1l6MYeIkAgVthA5emwEsL0fnmnM3UyXn5aSEX_Ybbqner3MrEJKjr1tMe-WuhKXscLl_63eVvTlmjyLrap9C4Cfu5wKUcx7NeDAoXit6U6RGVdsFJLPeHZtLRORq9JSdfdrJlGV7sLkzX0OZ1p8m_LKdpQTq-C3d6JMnGHevvwY3Q3IdbZ72t_AHEOTbM2sj8ZhmYbWrm0mmVt2y1ofDGLaWto3KCgL-wJes6vzhGXp3s9HQ6_84uGipmgzs61acIx_zH0taBTT7OHsL8eDqfnPA-qwL3OD_XvCwLaz3ComgL5YKUtY5SWtQUhfO1ciNl5KgWI9RXRalDHnJXGOmsUhbBpS0ewV7TNuEAWPQyt0ZGXxtZxhzFlTVea48YSCFMlBm83FK0uuxiZ1RDlORE_wrpXyX6V0UGh1uiV_08WlVXXM_g-VCMM4DMGrYJ7QbrKMqfTWF7Mnjc8Wj4XIEiR6tcZaB3uDdUoOjauyXNxc8UZRuhp0FtKoNXWz5f_da_e_Hk_714CrcFjbl0mPEQ9tbLTXiGqGbtjtLQPYL98Ydvn6f4fD-dffmKbydqgvdzMf4DvQ33Cw
link.rule.ids 230,314,780,784,885,12056,21388,27924,27925,31719,31720,33744,33745,41081,41120,41523,42150,42189,42592,43310,43805,51576,52111,52234
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVgIuiDeBAkbiBhaNHdsJFwTVVlvYXSEUpIpL5Dg29EBS9vH_mUm8qZYKlONYTjJjj7_xvABeORlsfVQ0XOXB8wwBArfCeq4KiY8RYojNWSz17Fv26UydxQu3dQyr3OnEXlE3naM78rfCUPc4PL7M-4vfnLpGkXc1ttC4DgdUOV1N4ODjdPnl6-hHEHnf6xHNdsFJMce0mT55jtZvximanbxZBZf7R9MVvHk1bPIv32l_JJ3cgdsRS7IPg_DvwjXf3oMbi-gtvw-hxIlZF5jbrjyzbcPqPl_lHVtvqcBxR43riE4g8BfOZOshMo5RXCebz6fld3beEpmNAek0nmoc8x8r23h2fLp8AOXJtDye8dhXgTvcoRueZdJah8AoWKlrr1RjglIWbUVRu0bXuS5U3ogcLVaRGZ_6tJaFqq3WFuGllQ9h0natfwwsOJXaQgXXFCoLKSosWzhjHKIgjUBRJfB6x9HqYqieUY11knv-V8j_qud_JRM43DG9ijtpXV3KPYGXIxn3ADk2bOu7LY7R1EGbCvck8GiQ0fg6iUrH6FQnYPakNw6g-tr7lPb8Z19nG8FngfZUAm92cr78rH__xZP__8ULuDkrF_Nqfrr8_BRuCVp_fWrjIUw2q61_hhhnUz-PC_kPrzD2bQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB2VIlVcEFA-Ai01Um9gldixHXOrSldt2a44bKWKS2Q7dumBbLXd_f_MJNnQpXCochzHSWbG8bNm5g3AfpDJ-c-25qpMkRcIELgTLnJlJV5GiC4353yiTy6Ks0t1eaeKv812X4Uku5oGYmlqFgc3dToYCt_I9wpOmegUibJcPoLHtBWRp1-IwyGOIMpS96Uy_75vfTu6hzHvp0r-FS9tt6HRM3ja40d22Bn8OWzE5gVsnfcR8m1IU5yYzRILy3lkrqmZb2tUvrDbJZEaz6hZHckJ-P3CmZzvsuEY5XKy8fh4-oNdNyRmQxI6jSdeY341d3VkR6eTlzAdHU-PTnjfS4EHXJULXhTSuYBgKDmpfVSqNkkph-dD4UOtfamtKmtR4ilVFCbmMffSKu-0dggpnXwFm82siW-ApaByZ1UKtVVFyvEn5WwwJiDy0QgOVQYfVxqtbjrGjGrgRm71X6H-q1b_lcxgZ6X0ql89t5Uw1CkQoYrJ4MMgRr-nYIZr4myJYzR1zSayngxedzYaHifxR2N0rjMwa9YbBhCn9rqkuf7Zcmsj4LR4hsrg08rOf17r_1_x9mHD92Dr-9dRNT6dfHsHTwS5Y1vduAObi_ky7iLMWfj3rSf_BqOg9D8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Test+of+cure+and+beyond%3A+superiority+of+thermal+ablation+over+LLETZ+in+the+treatment+of+high-grade+CIN&rft.jtitle=Archives+of+gynecology+and+obstetrics&rft.au=Armstrong%2C+G.+M.&rft.au=Ragupathy%2C+K.&rft.date=2022-11-01&rft.issn=1432-0711&rft.eissn=1432-0711&rft.volume=306&rft.issue=5&rft.spage=1815&rft.epage=1820&rft_id=info:doi/10.1007%2Fs00404-022-06409-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00404_022_06409_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1432-0711&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1432-0711&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1432-0711&client=summon